The Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine (N.C., C.N.S.), and Department of Medicine (J.M.D.), Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts; Department of Oral Medicine, Infection, and Immunity (C.N.S.), Harvard School of Dental Medicine, Boston, Massachusetts; Unit for Experimental Asthma and Allergy, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (S.-E.D.); GlaxoSmithKline, King of Prussia, Pennsylvania (D.W.P.H.); Division of Molecular Pharmacology, Pharmacological Sciences, Milan, Italy (G.E.R.); Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Tokyo, Tokyo, Japan (T.S.); Department of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University, Fu Kuoka, Japan (T.Y.); and Institut National de la Santé et de la Recherche Médicale U698, Hôpital Xavier Bichat secteur Claude Bernard, Paris, France (C.B.)

The Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine (N.C., C.N.S.), and Department of Medicine (J.M.D.), Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts; Department of Oral Medicine, Infection, and Immunity (C.N.S.), Harvard School of Dental Medicine, Boston, Massachusetts; Unit for Experimental Asthma and Allergy, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (S.-E.D.); GlaxoSmithKline, King of Prussia, Pennsylvania (D.W.P.H.); Division of Molecular Pharmacology, Pharmacological Sciences, Milan, Italy (G.E.R.); Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Tokyo, Tokyo, Japan (T.S.); Department of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University, Fu Kuoka, Japan (T.Y.); and Institut National de la Santé et de la Recherche Médicale U698, Hôpital Xavier Bichat secteur Claude Bernard, Paris, France (C.B.)

The Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine (N.C., C.N.S.), and Department of Medicine (J.M.D.), Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts; Department of Oral Medicine, Infection, and Immunity (C.N.S.), Harvard School of Dental Medicine, Boston, Massachusetts; Unit for Experimental Asthma and Allergy, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (S.-E.D.); GlaxoSmithKline, King of Prussia, Pennsylvania (D.W.P.H.); Division of Molecular Pharmacology, Pharmacological Sciences, Milan, Italy (G.E.R.); Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Tokyo, Tokyo, Japan (T.S.); Department of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University, Fu Kuoka, Japan (T.Y.); and Institut National de la Santé et de la Recherche Médicale U698, Hôpital Xavier Bichat secteur Claude Bernard, Paris, France (C.B.)

The Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine (N.C., C.N.S.), and Department of Medicine (J.M.D.), Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts; Department of Oral Medicine, Infection, and Immunity (C.N.S.), Harvard School of Dental Medicine, Boston, Massachusetts; Unit for Experimental Asthma and Allergy, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (S.-E.D.); GlaxoSmithKline, King of Prussia, Pennsylvania (D.W.P.H.); Division of Molecular Pharmacology, Pharmacological Sciences, Milan, Italy (G.E.R.); Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Tokyo, Tokyo, Japan (T.S.); Department of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University, Fu Kuoka, Japan (T.Y.); and Institut National de la Santé et de la Recherche Médicale U698, Hôpital Xavier Bichat secteur Claude Bernard, Paris, France (C.B.)

The Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine (N.C., C.N.S.), and Department of Medicine (J.M.D.), Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts; Department of Oral Medicine, Infection, and Immunity (C.N.S.), Harvard School of Dental Medicine, Boston, Massachusetts; Unit for Experimental Asthma and Allergy, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (S.-E.D.); GlaxoSmithKline, King of Prussia, Pennsylvania (D.W.P.H.); Division of Molecular Pharmacology, Pharmacological Sciences, Milan, Italy (G.E.R.); Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Tokyo, Tokyo, Japan (T.S.); Department of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University, Fu Kuoka, Japan (T.Y.); and Institut National de la Santé et de la Recherche Médicale U698, Hôpital Xavier Bichat secteur Claude Bernard, Paris, France (C.B.)

The Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine (N.C., C.N.S.), and Department of Medicine (J.M.D.), Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts; Department of Oral Medicine, Infection, and Immunity (C.N.S.), Harvard School of Dental Medicine, Boston, Massachusetts; Unit for Experimental Asthma and Allergy, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (S.-E.D.); GlaxoSmithKline, King of Prussia, Pennsylvania (D.W.P.H.); Division of Molecular Pharmacology, Pharmacological Sciences, Milan, Italy (G.E.R.); Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Tokyo, Tokyo, Japan (T.S.); Department of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University, Fu Kuoka, Japan (T.Y.); and Institut National de la Santé et de la Recherche Médicale U698, Hôpital Xavier Bichat secteur Claude Bernard, Paris, France (C.B.)

The Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine (N.C., C.N.S.), and Department of Medicine (J.M.D.), Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts; Department of Oral Medicine, Infection, and Immunity (C.N.S.), Harvard School of Dental Medicine, Boston, Massachusetts; Unit for Experimental Asthma and Allergy, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (S.-E.D.); GlaxoSmithKline, King of Prussia, Pennsylvania (D.W.P.H.); Division of Molecular Pharmacology, Pharmacological Sciences, Milan, Italy (G.E.R.); Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Tokyo, Tokyo, Japan (T.S.); Department of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University, Fu Kuoka, Japan (T.Y.); and Institut National de la Santé et de la Recherche Médicale U698, Hôpital Xavier Bichat secteur Claude Bernard, Paris, France (C.B.)

The Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine (N.C., C.N.S.), and Department of Medicine (J.M.D.), Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts; Department of Oral Medicine, Infection, and Immunity (C.N.S.), Harvard School of Dental Medicine, Boston, Massachusetts; Unit for Experimental Asthma and Allergy, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (S.-E.D.); GlaxoSmithKline, King of Prussia, Pennsylvania (D.W.P.H.); Division of Molecular Pharmacology, Pharmacological Sciences, Milan, Italy (G.E.R.); Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Tokyo, Tokyo, Japan (T.S.); Department of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University, Fu Kuoka, Japan (T.Y.); and Institut National de la Santé et de la Recherche Médicale U698, Hôpital Xavier Bichat secteur Claude Bernard, Paris, France (C.B.)

The Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine (N.C., C.N.S.), and Department of Medicine (J.M.D.), Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts; Department of Oral Medicine, Infection, and Immunity (C.N.S.), Harvard School of Dental Medicine, Boston, Massachusetts; Unit for Experimental Asthma and Allergy, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (S.-E.D.); GlaxoSmithKline, King of Prussia, Pennsylvania (D.W.P.H.); Division of Molecular Pharmacology, Pharmacological Sciences, Milan, Italy (G.E.R.); Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Tokyo, Tokyo, Japan (T.S.); Department of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University, Fu Kuoka, Japan (T.Y.); and Institut National de la Santé et de la Recherche Médicale U698, Hôpital Xavier Bichat secteur Claude Bernard, Paris, France (C.B.)